Hypernephroid
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy of Bevacizumab Plus RAD001 Versus Interferon Alfa-2a and Bevacizumab for the First-line Treatment in Adult Patients With Kidney Cancer (NCT00719264) | Novartis Pharmaceuticals | 2008-11-12 |
Track Hypernephroid automatically
Every clearance here is in the API, with alerts when new ones post.